Paul Jäger

523 total citations
23 papers, 312 citations indexed

About

Paul Jäger is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Paul Jäger has authored 23 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Paul Jäger's work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Paul Jäger is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Paul Jäger collaborates with scholars based in Germany, Netherlands and Switzerland. Paul Jäger's co-authors include Rainer Haas, Guido Kobbe, Thomas Schroeder, Stefanie Geyh, Christoph Zilkens, Frank Lyko, Manuel Rodríguez‐Paredes, Julian Gutekunst, Ulrich Germing and Ulrich Germing and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Paul Jäger

19 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Jäger Germany	9	232	89	82	66	48	23	312
Takanobu Morishita Japan	11	100 0.4×	107 1.2×	43 0.5×	42 0.6×	70 1.5×	37	268
Vicky Sandhu United States	8	270 1.2×	129 1.4×	79 1.0×	27 0.4×	57 1.2×	15	355
Andrew J. Menssen United States	7	172 0.7×	69 0.8×	64 0.8×	29 0.4×	26 0.5×	18	198
Carmen Sanzo Spain	5	166 0.7×	48 0.5×	84 1.0×	31 0.5×	24 0.5×	5	211
Yoshitoshi Ohtsuka Japan	9	138 0.6×	75 0.8×	62 0.8×	25 0.4×	38 0.8×	20	208
Kenneth Lieuw United States	9	203 0.9×	162 1.8×	56 0.7×	95 1.4×	45 0.9×	22	358
Chandrakala Shanmukhaiah India	11	228 1.0×	93 1.0×	140 1.7×	12 0.2×	18 0.4×	53	319
Galina Tsykunova Norway	8	147 0.6×	103 1.2×	25 0.3×	21 0.3×	30 0.6×	25	200
Diego V. Clé Brazil	9	79 0.3×	52 0.6×	53 0.6×	25 0.4×	26 0.5×	21	190
Melissa L. Larson United States	6	111 0.5×	89 1.0×	37 0.5×	29 0.4×	45 0.9×	30	210

Countries citing papers authored by Paul Jäger

Since Specialization

Citations

This map shows the geographic impact of Paul Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jäger more than expected).

Fields of papers citing papers by Paul Jäger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jäger. The network helps show where Paul Jäger may publish in the future.

Co-authorship network of co-authors of Paul Jäger

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Jäger. A scholar is included among the top collaborators of Paul Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Jäger. Paul Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scharf, Sebastian, Paul Jäger, Guido Kobbe, et al.. (2025). Dynamic Prediction of Mortality Risk Following Allogeneic Hematopoietic Stem Cell Transplantation. SHILAP Revista de lepidopterología.

Jäger, Paul, et al.. (2025). Diffuse large B-cell lymphoma mimicking metastatic melanoma: the importance of biopsies in the era of immune checkpoint inhibitors. Melanoma Research. 35(3). 197–200.

Kündgen, Andrea, Kathrin Nachtkamp, Paul Jäger, et al.. (2025). Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience. Annals of Hematology. 104(1). 231–239.

Koch, Annemarie, Roland Fenk, Uwe Maus, et al.. (2024). Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Advances. 8(10). 2575–2588. 4 indexed citations

Jäger, Paul, Johanna Tischer, Alessia Fraccaroli, et al.. (2024). Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies. Cancers. 16(3). 532–532. 6 indexed citations

Scharf, Sebastian, Birgit Henrich, Paul Jäger, et al.. (2024). Insights into gut microbiomes in stem cell transplantation by comprehensive shotgun long-read sequencing. Scientific Reports. 14(1). 4068–4068. 5 indexed citations

Moskorz, Wiebke, Paul Jäger, Ron‐Patrick Cadeddu, et al.. (2024). Characterization of CD34+ Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol. Cancers. 16(7). 1320–1320. 3 indexed citations

Koch, Annemarie, Ulrich Germing, Roland Fenk, et al.. (2024). Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms. Cancers. 16(11). 2071–2071. 1 indexed citations

Schroeder, Thomas, Matthias Stelljes, Maximilian Christopeit, et al.. (2023). Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial. Haematologica. 108(11). 3001–3010. 10 indexed citations

10.

Dembek, Till A., Julia Brandts, Paul Jäger, et al.. (2023). Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignancies. npj Digital Medicine. 6(1). 105–105. 7 indexed citations

11.

Jäger, Paul, Christina Rautenberg, Jennifer Kaivers, et al.. (2023). Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience. Scientific Reports. 13(1). 10774–10774. 2 indexed citations

12.

Rautenberg, Christina, Michael Lauseker, Jennifer Kaivers, et al.. (2021). Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS. European Journal Of Haematology. 107(2). 283–292. 15 indexed citations

13.

Moskorz, Wiebke, et al.. (2021). Myelodysplastic syndrome patients display alterations in their immune status reflected by increased PD‐L1‐expressing stem cells and highly dynamic exhausted T‐cell frequencies. British Journal of Haematology. 193(5). 941–945. 10 indexed citations

14.

Greinix, Hildegard, Ánita Lawitschka, Jörg Halter, et al.. (2021). Current practice in nutrition after allogeneic hematopoietic stem cell transplantation – Results from a survey among hematopoietic stem cell transplant centers. Clinical Nutrition. 40(4). 1571–1577. 25 indexed citations

15.

Schroeder, Thomas, Matthias Stelljes, Maximilian Christopeit, et al.. (2021). Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions - Final Results of the Prospective Azalena-Trial (NCT02472691). Blood. 138(Supplement 1). 411–411. 3 indexed citations

16.

Rautenberg, Christina, Ulrich Germing, Stefanie Stepanow, et al.. (2020). Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia. American Journal of Hematology. 96(1). E15–E17. 6 indexed citations

17.

Rautenberg, Christina, Ulrich Germing, Sabrina Pechtel, et al.. (2019). Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS. Blood Cancer Journal. 9(11). 86–86. 23 indexed citations

18.

Rautenberg, Christina, Stefanie Stepanow, Michael Lauseker, et al.. (2019). Impact of Somatic Mutations and Pretransplant Strategies on the Outcome of Patients Allografted for MDS or Secondary AML. Blood. 134(Supplement_1). 4612–4612.

19.

Geyh, Stefanie, Manuel Rodríguez‐Paredes, Paul Jäger, et al.. (2018). Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia. Haematologica. 103(9). 1462–1471. 47 indexed citations

20.

Geyh, Stefanie, Manuel Rodríguez‐Paredes, Paul Jäger, et al.. (2015). Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia. Leukemia. 30(3). 683–691. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact